Cell Based Assay Market, 2012 to 2023
Cell Based Assay Market is increased at a significant CAGR owing to rise in funding and investment for the R&D activities. Increase in the prevalence and incidence of chronic diseases such as cancer, drug discovery, increase in the government expenditure, and rise in the adoption of cell-based consumables by various organizations might fuel the cell-based assay market over the forecast period. Moreover, the rise in demand for biological drugs, increase the preference for toxicity screening in drugs, and reduction of cost associated with the drug discovery expected to boost the cell based assay market. However, lack of skilled professionals for conducting the cell based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of cell based Assay market.
Market Outline: Global Cell Based Assay Market
Cell based Assay is the analytical techniques to determine the different parameters such as biochemical or cellular functions of a living cell. Cell based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in the diagnostics and drug discovery. Cell based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others.
Cell based assay market segmented based on the product type, application, and end user
Based on the product type, cell based assay market segmented into the following:
Consumables
Assay Kits
Reagents
Cell growth assay
Reporter gene assay
Immortalized cell lines
Stem cell lines
Primary cell lines
Others
Based on the application, cell based assay market segmented into the following:
ADME studies
Basic research
Predictive toxicology
Drug discovery
Other
Based on the end user, cell-based Assay market segmented into the following
Diagnostic Centres
Hospitals
Biopharmaceutical companies
Contract research organizations
The cell based assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the cell based assay market growth.
Geographically, cell based assay market is segmented into, Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America expected to hold a major share in cell based assay market owing to increase in the prevalence of chronic diseases such as cancer, a rise in funding for the R&D activities, developed healthcare infrastructure, and innovation of novel drugs might propel the market growth. Europe holds a significant share in cell based assay market attributed to increase in the prevalence of chronic diseases such as cancer and immune disorders, change in lifestyle, increased healthcare expenditure, an increase in the focus of biopharmaceutical companies on the innovation of new products. Asia Pacific region is expected to grow at a significant rate due to increased investment by pharmaceutical companies, a rise in healthcare expenditure, an increase in the development of new drugs might bolster the cell based assay market over the forecast timeframe.
Some of the players in cell based assay market are PerkinElmer Inc. (U.S.), GE Healthcare (U.K), ProQinase GmbH (Germany), Danaher Corporation (U.S.), Essen BioScience Inc. (U.S.), Lonza Group (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abenex Capital SA (France), Axiogenesis AG (Germany), and Metrion Biosciences Ltd. (U.K.) to name a few.
In July 2016, Abenex acquired the Cisbio BioAssay from Argos Soditic for developing its product portfolio
Market Outline: Global Cell Based Assay Market
Cell based Assay is the analytical techniques to determine the different parameters such as biochemical or cellular functions of a living cell. Cell based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in the diagnostics and drug discovery. Cell based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others.
Cell based assay market segmented based on the product type, application, and end user
Based on the product type, cell based assay market segmented into the following:
Consumables
Assay Kits
Reagents
Cell growth assay
Reporter gene assay
Immortalized cell lines
Stem cell lines
Primary cell lines
Others
Based on the application, cell based assay market segmented into the following:
ADME studies
Basic research
Predictive toxicology
Drug discovery
Other
Based on the end user, cell-based Assay market segmented into the following
Diagnostic Centres
Hospitals
Biopharmaceutical companies
Contract research organizations
The cell based assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the cell based assay market growth.
Geographically, cell based assay market is segmented into, Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America expected to hold a major share in cell based assay market owing to increase in the prevalence of chronic diseases such as cancer, a rise in funding for the R&D activities, developed healthcare infrastructure, and innovation of novel drugs might propel the market growth. Europe holds a significant share in cell based assay market attributed to increase in the prevalence of chronic diseases such as cancer and immune disorders, change in lifestyle, increased healthcare expenditure, an increase in the focus of biopharmaceutical companies on the innovation of new products. Asia Pacific region is expected to grow at a significant rate due to increased investment by pharmaceutical companies, a rise in healthcare expenditure, an increase in the development of new drugs might bolster the cell based assay market over the forecast timeframe.
Some of the players in cell based assay market are PerkinElmer Inc. (U.S.), GE Healthcare (U.K), ProQinase GmbH (Germany), Danaher Corporation (U.S.), Essen BioScience Inc. (U.S.), Lonza Group (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abenex Capital SA (France), Axiogenesis AG (Germany), and Metrion Biosciences Ltd. (U.K.) to name a few.
In July 2016, Abenex acquired the Cisbio BioAssay from Argos Soditic for developing its product portfolio
1. EXECUTIVE SUMMARY
2. GLOBAL CELL BASED ASSAY MARKET INTRODUCTION
2.1. Global Cell Based Assay Market – Taxonomy
2.2. Global Cell Based Assay Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL CELL BASED ASSAY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cell Based Assay Market Dynamics – Factors Impact Analysis
3.6. Global Cell Based Assay Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL CELL BASED ASSAY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Consumables
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Assay Kits
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Reagents
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Cell growth assay
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Reporter gene assay
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Immortalized cell lines
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Stem cell lines
5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Primary cell lines
5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY APPLICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. ADME studies
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Basic research
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Predictive toxicology
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Drug discovery
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Diagnostic Centres
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hospitals
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Biopharmaceutical companies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Contract research organizations
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User, and Region, 2017 – 2023
9. NORTH AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Consumables
9.1.2. Assay Kits
9.1.3. Reagents
9.1.4. Cell growth assay
9.1.5. Reporter gene assay
9.1.6. Immortalized cell lines
9.1.7. Stem cell lines
9.1.8. Primary cell lines
9.1.9. Others
9.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. ADME studies
9.2.2. Basic research
9.2.3. Predictive toxicology
9.2.4. Drug discovery
9.2.5. Other
9.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Diagnostic Centres
9.3.2. Hospitals
9.3.3. Biopharmaceutical companies
9.3.4. Contract research organizations
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
9.6. North America Cell Based Assay Market Dynamics – Trends
10. EUROPE CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Assay Kits
10.1.3. Reagents
10.1.4. Cell growth assay
10.1.5. Reporter gene assay
10.1.6. Immortalized cell lines
10.1.7. Stem cell lines
10.1.8. Primary cell lines
10.1.9. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. ADME studies
10.2.2. Basic research
10.2.3. Predictive toxicology
10.2.4. Drug discovery
10.2.5. Other
10.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diagnostic Centres
10.3.2. Hospitals
10.3.3. Biopharmaceutical companies
10.3.4. Contract research organizations
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
10.6. Europe Cell Based Assay Market Dynamics – Trends
11. ASIA-PACIFIC CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Assay Kits
11.1.3. Reagents
11.1.4. Cell growth assay
11.1.5. Reporter gene assay
11.1.6. Immortalized cell lines
11.1.7. Stem cell lines
11.1.8. Primary cell lines
11.1.9. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. ADME studies
11.2.2. Basic research
11.2.3. Predictive toxicology
11.2.4. Drug discovery
11.2.5. Other
11.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diagnostic Centres
11.3.2. Hospitals
11.3.3. Biopharmaceutical companies
11.3.4. Contract research organizations
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
11.6. Europe Cell Based Assay Market Dynamics – Trends
12. LATIN AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Assay Kits
12.1.3. Reagents
12.1.4. Cell growth assay
12.1.5. Reporter gene assay
12.1.6. Immortalized cell lines
12.1.7. Stem cell lines
12.1.8. Primary cell lines
12.1.9. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. ADME studies
12.2.2. Basic research
12.2.3. Predictive toxicology
12.2.4. Drug discovery
12.2.5. Other
12.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diagnostic Centres
12.3.2. Hospitals
12.3.3. Biopharmaceutical companies
12.3.4. Contract research organizations
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
12.6. Latin America Cell Based Assay Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Assay Kits
13.1.3. Reagents
13.1.4. Cell growth assay
13.1.5. Reporter gene assay
13.1.6. Immortalized cell lines
13.1.7. Stem cell lines
13.1.8. Primary cell lines
13.1.9. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. ADME studies
13.2.2. Basic research
13.2.3. Predictive toxicology
13.2.4. Drug discovery
13.2.5. Other
13.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostic Centres
13.3.2. Hospitals
13.3.3. Biopharmaceutical companies
13.3.4. Contract research organizations
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
13.6. MEA Cell Based Assay Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. PerkinElmer Inc. (U.S.)
14.2.2. GE Healthcare (UK)
14.2.3. ProQinase GmbH (Germany)
14.2.4. Danaher Corporation (U.S.)
14.2.5. Essen BioScience Inc. (U.S.)
14.2.6. Lonza Group (U.S.)
14.2.7. Thermo Fisher Scientific Inc. (U.S.)
14.2.8. Abenex Capital SA (France)
14.2.9. Axiogenesis AG (Germany)
14.2.10. Metrion Biosciences Ltd. (UK.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL CELL BASED ASSAY MARKET INTRODUCTION
2.1. Global Cell Based Assay Market – Taxonomy
2.2. Global Cell Based Assay Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL CELL BASED ASSAY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cell Based Assay Market Dynamics – Factors Impact Analysis
3.6. Global Cell Based Assay Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL CELL BASED ASSAY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Consumables
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Assay Kits
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Reagents
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Cell growth assay
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Reporter gene assay
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Immortalized cell lines
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Stem cell lines
5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Primary cell lines
5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY APPLICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. ADME studies
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Basic research
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Predictive toxicology
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Drug discovery
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Diagnostic Centres
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hospitals
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Biopharmaceutical companies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Contract research organizations
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User, and Region, 2017 – 2023
9. NORTH AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Consumables
9.1.2. Assay Kits
9.1.3. Reagents
9.1.4. Cell growth assay
9.1.5. Reporter gene assay
9.1.6. Immortalized cell lines
9.1.7. Stem cell lines
9.1.8. Primary cell lines
9.1.9. Others
9.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. ADME studies
9.2.2. Basic research
9.2.3. Predictive toxicology
9.2.4. Drug discovery
9.2.5. Other
9.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Diagnostic Centres
9.3.2. Hospitals
9.3.3. Biopharmaceutical companies
9.3.4. Contract research organizations
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
9.6. North America Cell Based Assay Market Dynamics – Trends
10. EUROPE CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Assay Kits
10.1.3. Reagents
10.1.4. Cell growth assay
10.1.5. Reporter gene assay
10.1.6. Immortalized cell lines
10.1.7. Stem cell lines
10.1.8. Primary cell lines
10.1.9. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. ADME studies
10.2.2. Basic research
10.2.3. Predictive toxicology
10.2.4. Drug discovery
10.2.5. Other
10.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diagnostic Centres
10.3.2. Hospitals
10.3.3. Biopharmaceutical companies
10.3.4. Contract research organizations
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
10.6. Europe Cell Based Assay Market Dynamics – Trends
11. ASIA-PACIFIC CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Assay Kits
11.1.3. Reagents
11.1.4. Cell growth assay
11.1.5. Reporter gene assay
11.1.6. Immortalized cell lines
11.1.7. Stem cell lines
11.1.8. Primary cell lines
11.1.9. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. ADME studies
11.2.2. Basic research
11.2.3. Predictive toxicology
11.2.4. Drug discovery
11.2.5. Other
11.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diagnostic Centres
11.3.2. Hospitals
11.3.3. Biopharmaceutical companies
11.3.4. Contract research organizations
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
11.6. Europe Cell Based Assay Market Dynamics – Trends
12. LATIN AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Assay Kits
12.1.3. Reagents
12.1.4. Cell growth assay
12.1.5. Reporter gene assay
12.1.6. Immortalized cell lines
12.1.7. Stem cell lines
12.1.8. Primary cell lines
12.1.9. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. ADME studies
12.2.2. Basic research
12.2.3. Predictive toxicology
12.2.4. Drug discovery
12.2.5. Other
12.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diagnostic Centres
12.3.2. Hospitals
12.3.3. Biopharmaceutical companies
12.3.4. Contract research organizations
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
12.6. Latin America Cell Based Assay Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Assay Kits
13.1.3. Reagents
13.1.4. Cell growth assay
13.1.5. Reporter gene assay
13.1.6. Immortalized cell lines
13.1.7. Stem cell lines
13.1.8. Primary cell lines
13.1.9. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. ADME studies
13.2.2. Basic research
13.2.3. Predictive toxicology
13.2.4. Drug discovery
13.2.5. Other
13.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostic Centres
13.3.2. Hospitals
13.3.3. Biopharmaceutical companies
13.3.4. Contract research organizations
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
13.6. MEA Cell Based Assay Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. PerkinElmer Inc. (U.S.)
14.2.2. GE Healthcare (UK)
14.2.3. ProQinase GmbH (Germany)
14.2.4. Danaher Corporation (U.S.)
14.2.5. Essen BioScience Inc. (U.S.)
14.2.6. Lonza Group (U.S.)
14.2.7. Thermo Fisher Scientific Inc. (U.S.)
14.2.8. Abenex Capital SA (France)
14.2.9. Axiogenesis AG (Germany)
14.2.10. Metrion Biosciences Ltd. (UK.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
